Fundraising Fox

IsoRay

NYSE: CATX

Richland, US · Delaware corporation

Healthtech

Founders & leadership

WC
William CavanaghNamed on SEC filing
MW
Michael W McCormickNamed on SEC filing
LA
Lori A WoodsNamed on SEC filing
JS
Jennifer StreeterNamed on SEC filing
MJ
Mark J AustinNamed on SEC filing
MK
Michael KrachonNamed on SEC filing
AH
Alan HoffmannNamed on SEC filing
PJ
Philip J VitaleNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$163.6M disclosed across 4 rounds · 2018–2024

▶$87.4MraisedMar 2024 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert Williamson IIIDirector
  • Frank MorichDirector
  • Johan (Thijs) SpoorExecutive Officer, Director
  • Lori WoodsDirector
  • Mark AustinExecutive Officer
  • Heidi HensonDirector
  • Jonathan HuntExecutive Officer
  • Markus PuhlmannExecutive Officer
Offering amount
$87.4M
Amount sold
$87.4M
Sales commissions
$5.1M
Placement agents
LifeSci Capital, LLC, Oppenheimer & Co. Inc., B. Riley Securities, Inc., JonesTrading Institutional Services LLC
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.8MraisedJan 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert Williamson IIIDirector
  • Markus PuhlmannExecutive Officer
  • Mark AustinExecutive Officer
  • Johan (Thijs) SpoorExecutive Officer, Director
  • Frank MorichDirector
  • Heidi HensonDirector
  • Jonathan HuntExecutive Officer
  • Lori WoodsDirector
Offering amount
$20.8M
Amount sold
$20.8M
Minimum investment
$20.8M
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$54.6MraisedFeb 2023 · 54 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Lori WoodsDirector
  • Mark AustinExecutive Officer
  • Markus PuhlmannExecutive Officer
  • Johan (Thijs) SpoorExecutive Officer, Director
  • Frank MorichDirector
  • Robert Williamson IIIDirector
  • Michael McCormickDirector
  • Jennifer StreeterExecutive Officer
  • Jonathan HuntExecutive Officer
Offering amount
$54.6M
Amount sold
$54.6M
Minimum investment
$28.5K
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$728.8KraisedJul 2018 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William CavanaghExecutive Officer
  • Michael W McCormickDirector
  • Lori A WoodsExecutive Officer, Director
  • Jennifer StreeterExecutive Officer
  • Mark J AustinExecutive Officer
  • Michael KrachonExecutive Officer
  • Alan HoffmannDirector
  • Philip J VitaleDirector
Offering amount
$728.8K
Amount sold
$728.8K
Sales commissions
$46.2K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jul 2018
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

IsoRay Medical, Inc. Announces 1st Round Of Institutional Financing Led By MicroCapital LLC; Raising Over $5 Million - BioSpacebiospace.com · Aug 2006Buy IsoRay Stock – ISR Stock Quote Today & Investment Insights - Public.compublic.com

Frequently asked questions

How much funding has IsoRay raised?
IsoRay has disclosed $163.6M raised across 4 rounds.
Where is IsoRay headquartered?
IsoRay is headquartered in Richland, US.